Recent news on Radiopharmaceuticals

DRAXIS Manufacturing Facilities Pass Extensive FDA Inspection  -  May 23, 2007
CNW Telbec (Communiqués de presse),Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are

Safeguard Scientifics Co-Leads $26 Million Series C Financing for ...  -  May 9, 2007
American Venture Magazine (press release),Avid Radiopharmaceuticals, Inc. is developing novel diagnostic imaging agents to enable earlier and more accurate diagnosis, treatment selection and

Phila. start-up developing a way to test for Alzheimer's  -  May 9, 2007
Philadelphia Inquirer,Avid Radiopharmaceuticals Inc. was spun out of research at the University of Pennsylvania. It has just raised $26 million in venture financing,

SNM Seeks to Improve Patient Care by Advancing Molecular Imaging ...  -  May 9, 2007
DOTmed.com (press release),...including computational and instrumental needs, impediments to the approval and distribution of radiopharmaceuticals, impact of isotope shortages and

DRAXIS Health Reports Results for the First Quarter of 2007  -  May 9, 2007
CNW Telbec (Communiqués de presse),Radiopharmaceuticals - Product sales revenues for the first quarter of 2007 were up 18% to $5.8 million compared to the first quarter of 2006 as a result of

Avid Raises $26M In Series C For Molecular imaging Agents  -  May 9, 2007
Therapeutics Daily (subscription) (press release),Avid Radiopharmaceuticals Inc. raised $26 million in a Series C financing to advance development of its diagnostic molecular imaging compounds for

Funding Life and Sciences  -  May 9, 2007
Red Herring,And in Philadelphia , Avid Radiopharmaceuticals has raised $26 million in Series C funding. The lead financiers were Safeguard Scientifics and

Experimental Committee Focuses on Innovative Research  -  May 9, 2007
DOTmed.com (press release),Committee members will have a broad range of expertise, from researchers specializing in cancer biology to experts in radiopharmaceuticals and other

Eckert & Ziegler increases earnings by 17%  -  May 8, 2007
PresseBox (Pressemitteilung)(abonnement),The Therapy segment raised its earnings from 160000 to 350000 EUR, while the Radiopharmaceuticals segment, which is currently under development,

Scientific process chillers available from Summit Matsu Chilling ...  -  Apr 29, 2007
Ferret,...process water chiller is used for autoclave cooling and temperature regulation as part of the sterilisation in the radiopharmaceuticals division.

TLC scanner 'more accurate than cut-and-count'  -  Apr 25, 2007
Laboratory Talk,The Leeds Teaching Hospitals NHS Trust purchased the scanner for the quality control of beta-emitting radiopharmaceuticals, but it has also found a role

TLC scanner 'more accurate than cut-and-count'  -  26 Apr 2007
Laboratory Talk,The Leeds Teaching Hospitals NHS Trust purchased the scanner for the quality control of beta-emitting radiopharmaceuticals, but it has also found a role

New molecular imaging agent identifies Alzheimer’s disease  -  Apr 24, 2007
MTBeurope,The result of the first clinical study of the compound was announced by manufacturer Avid Radiopharmaceuticals, Inc. (Avid) and the findings were presented

MDS Nordion Enters Collaboration Agreement with Avid ...  -  Apr 5, 2007
Drug Newswire (press release),Avid is a pioneer in the development of radiopharmaceuticals for imaging Alzheimer's disease pathology. Increasingly, molecular imaging is being used as a

MDS Nordion Enters Collaboration Agreement With Avid ...  -  Apr 4, 2007
Medical News Today (press release),MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, has entered into a collaboration agreement

MDS Nordion Enters Collaboration Agreement with Avid ...  -  Apr 4, 2007
PR-Inside.com (Pressemitteilung),...the development of radiopharmaceuticals for imaging Alzheimer's disease pathology. Increasingly, molecular imaging is being used as a biomarker tool to

MDS Nordion Enters Collaboration Agreement with Avid ...  -  Apr 4, 2007
Earthtimes.orgOTTAWA, April 4 -- MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, has entered into a

MDS Nordion Reveals Collaboration Deal With Avid ...  -  Apr 4, 2007
Trading Markets,TO, MDZ) said that it has entered into a collaboration agreement with molecular imaging company Avid Radiopharmaceuticals Inc. to support clinical studies

MDS Nordion to help develop Avid Radiopharmaceuticals's products  -  Apr 4, 2007
Ottawa Business Journal,Ottawa-based MDS Nordion is partnering with Philadelphia-based Avid Radiopharmaceuticals Inc. to help Avid develop its Alzheimer's disease detection and

PET Is Alive and Well  -  Mar 30, 2007
Journal of Nuclear Medicine (subscription)The chief obstacle then and now is obtaining approval of PET radiopharmaceuticals from the Food and Drug Administration (FDA) and Medicare.

DRAXIS to Present at the Scotia Capital 2007 Spring Growth Conference  -  Mar 29, 2007
Drug Newswire (press release),Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are

MD Anderson, Health Science Center break ground on research facility  -  Apr 11, 2007
San Antonio Business Journal,...molecular and cellular biology and facilities for production of clinical-grade imaging agents such as radiopharmaceuticals, nanoparticle-based agents,

Nuclear Cardiology Technologist  -  Mar 31, 2007
Kingsport Times News,...necessary in the completion of nuclear cardiology procedures *Administering radiopharmaceuticals by various IV routes * Preparing radiopharmaceuticals

DGAP-News: Eckert & Ziegler 2006: Record Sales and Growth in Earnings  -  Mar 28, 2007
Frankfurter Allgemeine Zeitung,The Therapy segment specializing in medical devices for the treatment of cancer earned 0.27 EUR per share, while the new Radiopharmaceuticals segment on the

Algeta gets IPO away safely  -  Mar 28, 2007
Science Business (subscription),Radiopharmaceuticals specialist Algeta ASA, of Oslo, Norway, successfully closed its initial public offering, raising NOK 250 million.

Molecular Insight Pharmaceuticals, Inc. Announces Appointment of ...  -  Apr 23, 2007
PharmaLive.com (press release),..."Molecular Insight leads the field of molecular medicine and radiopharmaceuticals with product candidates that may offer significant benefit to patients

Researcher’s enhanced drug moves to clinical trials  -  Apr 12, 2007
News@UofT,The nuclear pharmacologist makes radiopharmaceuticals -- drugs that have been labelled with safe amounts of radioactive substances.

New reactor open for business  -  Apr 19, 2007
Sydney Morning Herald,The Australian Nuclear Science and Technology Organisation, which runs Lucas Heights, already produces 70 per cent of the radiopharmaceuticals used in

FDA Announces Recommendations to Reauthorize Medical Device User ...  -  Apr 18, 2007
Compliance Home,...the processes and to clarify the data requirements for the approval or clearance of imaging devices that use contrast agents or radiopharmaceuticals.

Molecular Insight Pharmaceuticals, Inc. Announces Appointment of ...  -  Apr 18, 2007
PharmaLive.com (press release),..."Molecular Insight is the leading innovator in the discovery and development of molecular targeting radiopharmaceuticals, and I am very pleased to be

Molecular Insight Pharmaceuticals, Inc. Announces Appointment of ...  -  Apr 18, 2007
Business Wire (press release),...“Molecular Insight is the leading innovator in the discovery and development of molecular targeting radiopharmaceuticals, and I am very pleased to be

Nuclear Imaging Drug Development Tools  -  Apr 13, 2007
Genetic Engineering News (press release),The quality of the final product is highly dependent on the quality of the starting materials. Preparing radiopharmaceuticals is no exception.

Nuclear legend farewelled  -  Apr 5, 2007
Daily Telegraph,It was first used to make radiopharmaceuticals and test materials for the development of nuclear energy in Australia.

Industry News in Brief  -  Apr 5, 2007
LabTechnologist.com,MDS Nordion has entered into an agreement with molecular imaging company Avid Radiopharmaceuticals to radiolabel Avid's proprietary compounds for use in

ASTRO/ACR Guide To Radiation Oncology Coding 2007 Now Available  -  Mar 30, 2007
Medical News Today (press release),It also includes information on radioimmunotherapy, radiopharmaceuticals and microsphere brachytherapy. The guide is complete with coding recommendations,

Timothy R. Wright Appointed President of Tyco Healthcare's ...  -  Mar 28, 2007
Drug Newswire (press release),Its $900 million Imaging Solutions business is an industry leader in medical imaging -- providing a full line of radiopharmaceuticals, contrast media and

DRAXIS to Present at the Scotia Capital 2007 Spring Growth Conference  -  27 Mar 2007
CNW Telbec (Communiqués de presse),Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are

DRAXIS to Host Analyst and Investor Day  -  Mar 20, 2007
PharmaLive.com (press release),Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are

Avid Announces Results Of Av-1 Molecular Imaging Agent For ...  -  Mar 19, 2007
Medical News Today (press release),Avid Radiopharmaceuticals, Inc. (Avid), a product-focused molecular imaging company, today announced the presentation of the first results from a clinical

Avid Announces Results of AV-1 Molecular Imaging Agent for ...  -  Mar 19, 2007
Business Wire (press release),Avid Radiopharmaceuticals, Inc. is developing novel diagnostic imaging agents to enable the early diagnosis, treatment selection and therapeutic monitoring

Brain Scan Advance Could Diagnose Alzheimer's  -  Mar 20, 2007
HealthCentral.com,...to deposit," confirmed Alan Carpenter, vice president of business development at Avid Radiopharmaceuticals in Philadelphia, which licensed the compound.

Innovative cancer treatments from Geneva  -  Mar 16, 2007
Imprint,Their research in the medical field alone is worth noting, as it has aided in the development of several radiopharmaceuticals such as the Positron Emission

Congresswoman Heather Wilson Visits New Mexico Center for Isotopes ...  -  Mar 6, 2007
UNM Today,The idea behind molecular targeting is to design radiopharmaceuticals that specifically target the molecular pathways that cause disease, without disrupting

Healthy Global Market for Contrasting Agents Growing to $15 ...  -  Mar 9, 2007
PR Leap (press release),...“However, developers of new contrast agents and radiopharmaceuticals are faced with regulatory requirements to prove both safety and efficacy of their

Iran launches production of diagnostic radiopharmaceutical  -  Mar 11, 2007
PRESS TV,Chairmen of the research center, Mohammad Qannadi, said at the inaugural ceremony, "Utilization of diagnostic radiopharmaceuticals has grown in Iran in

Chromatography data system runs 'hot' and 'cold'  -  Mar 13, 2007
separationsNOW.com (press release),In addition, LabLogic recently developed a bespoke module for a gas chromatograph being used in the rapidly expanding PET radiopharmaceuticals industry.

5 Low-Priced, High-Star Stocks  -  Feb 27, 2007
Motley FoolDRAXIS' strategy is to focus on specialty markets -- like radiopharmaceuticals and freeze-dried injectables -- to develop a sustainable competitive

IAEA freezes cuts technical aid for Iran's nuclear programs  -  Mar 9, 2007
Earthtimes.orgProjects involving radiopharmaceuticals and isotopes for medical, agriculture and humanitarian applications will continue to receive aid.

Watchdog approves aid cut to Iran  -  Mar 9, 2007
Turkish Daily News (subscription),...measures in developing nuclear fuel. Projects that were spared involve radiopharmaceuticals and isotopes for medical, agriculture and humanitarian purposes.

IAEA governors ratify cut in N-aid to Iran  -  Mar 8, 2007
Financial Express.bd,Projects that were spared involve radiopharmaceuticals and isotopes for medical, agriculture and humanitarian purposes.

MDS Nordion to expand European plant in Belgium with US$5.8 ...  -  Mar 1, 2007
Canada.com,OTTAWA (CP) - MDS Inc.'s Nordion unit (TSX:MDS), a producer of medical isotopes and radiopharmaceuticals for cancer treatments and molecular imaging,

Euromedic: new diagnostics centres with PETs  -  Mar 1, 2007
Polish Market,...a device for manufacture of radiopharmaceuticals administered to patients before PET-CT examination, manufactured by General Electric Healthcare.

Nuclear Medicine Practitioner Competencies  -  Mar 2, 2007
Journal of Nuclear Medicine Technology (subscription)Evaluate patient medication and radiopharmaceuticals for testing and contraindication to testing and indicators of patient pathology.

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 23, 2007
Drug Newswire (press release),OTTAWA, March 1 /PRNewswire-FirstCall/ -- MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging,

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 21, 2007
Assodigitale,IT) MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing US US$5.8 million / (euro) 4.5

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 21, 2007
PR Newswire UK (press release),MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing US US$5.8 million / (euro) 4.5

Timothy R. Wright Appointed President of Tyco Healthcare's ...  -  Mar 20, 2007
PR Newswire (press release),Its $900 million Imaging Solutions business is an industry leader in medical imaging -- providing a full line of radiopharmaceuticals, contrast media and

Positron Expands on Its Entry into Radiation Detection Devices for ...  -  Mar 18, 2007
dBusinessNews Houston (press release),A PET (“Positron Emission Tomography�) scanner is a sensitive radiation detection device that detects cancer-seeking radiopharmaceuticals injected into the

Positron enters homeland security market, seeks radiation ...  -  Mar 15, 2007
Military & Aerospace Electronics,A PET scanner detects cancer-seeking radiopharmaceuticals injected into the human body. PET scanners operate at close distances to the body,

Positron Expands on Its Entry into Radiation Detection Devices for ...  -  Mar 14, 2007
American Digital Networks (press release),A PET ("Positron Emission Tomography") scanner is a sensitive radiation detection device that detects cancer-seeking radiopharmaceuticals injected into the

Analyst initiations 3-14-07: Time Warner Cable & Tim Hortons ...  -  Mar 14, 2007
Blogging StocksRBC said Molecular Insight is a leader in developing and commercializing superior radiopharmaceuticals for the treatment and management of life-threatening

Advanced Medical Isotopes Corporation Purchases North America's ...  -  Mar 13, 2007
Primenewswire (press release),Washington announces its plans to commission a facility for the production of radiopharmaceuticals used in Positron Emission Tomography (PET) imaging

US Demand for Medical Imaging Products to Reach $21.4 Billion in 2010  -  Mar 9, 2007
Advanced Imaging Pro (press release),Radiopharmaceuticals will provide the best growth opportunities based on rising numbers of nuclear medicine and PET procedures as well as increasing

IAEA ratifies Iran atom aid cut  -  Mar 8, 2007
Today's Zaman,Projects that were spared involve radiopharmaceuticals and isotopes for medical, agriculture and humanitarian purposes. Iran ignored a Feb.

UN atomic agency cuts aid to Iran  -  Mar 8, 2007
Middle East Times,Examples from the IAEA report show approval of a project to help Iran "prepare therapeutic sources ... and radiopharmaceuticals for cancer treatment,"

Myocardial Perfusion Imaging Protocols: Is There an Ideal Protocol? *  -  Mar 2, 2007
Journal of Nuclear Medicine Technology (subscription)In order to answer this question and choose a protocol for clinical use, one must understand the characteristics of the available radiopharmaceuticals,

Alpha results for new cancer radiotherapy  -  Mar 2, 2007
DrugResearcher.com,...cells more quickly than radioactive compounds that emit beta-radiation - the majority of current radiopharmaceuticals rely on beta-emitting particles.

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 1, 2007
Assodigitale,MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing US $5.8 million / (euro) 4.5 million

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 1, 2007
FinanzNachrichten.de,MDS (Nachrichten) Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing US $5.8 million

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 1, 2007
news aktuell (Pressemitteilung),...in Supply of Glucotrace(R) for Growing Market MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging,

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 1, 2007
Earthtimes.orgOTTAWA, March 1 -- MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing US $5.8 million

MDS Nordion to Expand Facility to Meet Growing Demand for Medical ...  -  Mar 1, 2007
PR Newswire (press release),March 1 /PRNewswire-FirstCall/ - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing

NRC Appointments New Member to Advisory Committee on Medical Uses ...  -  Feb 28, 2007
DOTmed.com (press release),Dr. Fisher, a medical physicist with experience in the dosimetry and health effects of radionuclides and radiopharmaceuticals used for diagnosing and

Chemistry platform to speed molecular imaging  -  Feb 27, 2007
Laboratory Talk,In partnering with McMaster University, Biotage can play an important role in advancing the development of radiopharmaceuticals.

Biotage AB and McMaster University Sign Joint Agreement to Develop ...  -  Feb 26, 2007
PharmaLive.com (press release),In partnering with McMaster University, Biotage can play an important role in advancing the development of radiopharmaceuticals. Speed, yield, purity and

DRAXIS Radiopharmaceuticals Division Applies to FDA to Market ...  -  Feb 5, 2007
Drug Newswire (press release),DRAXIMAGE develops, manufactures and markets diagnostic and therapeutic radiopharmaceuticals for the global marketplace. Products currently include a line

DRAXIS Radiopharmaceuticals Division Applies to FDA to Market ...  -  Feb 2, 2007
CNW Telbec (Communiqués de presse),About DRAXMAGE DRAXIMAGE develops, manufactures and markets diagnostic and therapeutic radiopharmaceuticals for the global marketplace.

The Cost of Bringing a Radiopharmaceutical to the Patient's Bedside  -  Jan 31, 2007
Journal of Nuclear Medicine (subscription)Will the opportunity be fulfilled and growth maintained using only currently approved radiopharmaceuticals? What will be the fate of new

DRAXIS to Present at the 2007 UBS Global Healthcare Services ...  -  Feb 6, 2007
CNW Telbec (Communiqués de presse),Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are

Australia decommissions first reactor  -  Feb 14, 2007
Nuclear Engineering,Based on a British reactor design, initially HIFAR was used to make radiopharmaceuticals and test materials for the development of nuclear energy in

DRAXIS Posts Record Earnings and Cash Flow for 2006  -  Feb 8, 2007
CNW Telbec (Communiqués de presse),Radiopharmaceuticals - Revenues for the fourth quarter of 2006 were up 14% to $5.6 million compared to the same period in 2005 (up over 20% after adjusting

Nuclear over-reaction  -  Feb 3, 2007
Daily Telegraph,As radiopharmaceuticals decay quickly and so become ineffective, research has lengthened their life-span so that they might be transported across the

IAEA curbs technical cooperation with Iran  -  Feb 9, 2007
Hindustan Times,Among the projects Iran requested were technical assistance for developing a waste disposal facility and aid for the production of radiopharmaceuticals for

IAEA cuts back Iran N-aid to uphold sanctions  -  Feb 10, 2007
IranMania News,Examples from the IAEA report show approval of a project to help Iran "prepare therapeutic sources . . . and radiopharmaceuticals for cancer treatment,"

UN atomic agency almost halves aid to Iran  -  Feb 9, 2007
France24,The IAEA report Friday approved one national project to help Iran "prepare therapeutic sources, radiocolloid particles and radiopharmaceuticals for cancer

MDS Nordion Establishes European Centers of Excellence for ...  -  Feb 8, 2007
Earthtimes.org8 -- MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used to diagnose and treat disease, has established four Centers of

MDS Nordion Establishes European Centers of Excellence for ...  -  Feb 8, 2007
PR Newswire (press release),8 /PRNewswire-FirstCall/ - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used to diagnose and treat disease,

Draxis Health submits Sestamibi medical imaging agent for FDA approval  -  Feb 2, 2007
Canada.com,...will be a key factor in determining future sales for this product." Draxis develops sterile products, non-sterile products and radiopharmaceuticals.

Draxis submits medical imaging agent for FDA approval  -  Feb 2, 2007
Globe and Mail,...will be a key factor in determining future sales for this product.� Draxis develops sterile products, non-sterile products and radiopharmaceuticals.

Market Report -- In Play (DRAX)  -  Feb 2, 2007
MSN MoneyDraxis Health's radiopharmaceuticals division applies to FDA to market cardiac imaging product Co announces the radiopharmaceutical division of DRAXIS

Pre-Market Stock Notes (FEB 2, 2007)  -  Feb 2, 2007
24/7 Wall St.,...(DRAX) Draxis Health's radiopharmaceuticals division applies to FDA to market cardiac imaging product. (EOP) Equity Office is reaffirming the commitment to

Sección internacional  -  Feb 2, 2007
Bolsamania.com,...(PRN) - DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product ... [+]. (PRN) - Famous Uncle Al's Hot Dogs & Grille,

Readers Respond to "Is There Life After PET?"  -  Jan 31, 2007
DOTmed.com (press release),These two radiopharmaceuticals cover 99% of the Oncology, Neurology and Cardiology clinical imaging done in PET/CT today. As market leaders, PETNET,

Reply: Log Normal Distribution of Cellular Uptake of Radioactivity  -  Jan 31, 2007
Journal of Nuclear Medicine (subscription)Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. J Nucl Med. 2006;47:1049–1058.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional